Marie-Christine Jaulent

Marie-Christine Jaulent

Auto-generated profile, based on publicly available information

Marie-Christine Jaulent

Sorbonne Université, INSERM, Université Paris-Nord, Limics, Paris, France

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2015 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JLJérémy Lardon
Jérémy Lardon
RARedhouane Abdellaoui
Redhouane Abdellaoui
FBFlorelle Bellet
Florelle Bellet
HAHadyl Asfari
Hadyl Asfari
JSJulien Souvignet
Julien Souvignet
CBCédric Bousquet
Cédric Bousquet
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 December 2011 in Journal of Biomedical Informatics
Verified
Journal Article
Open access
AFAbdenNaji El Fadly
AbdenNaji El Fadly
BRBastien Rance
Bastien Rance
NLNoël Lucas
Noël Lucas
CMCharles Mead
Charles Mead
GCGilles Chatellier
Gilles Chatellier
CDChristel Daniel
Christel Daniel
There are different approaches for repurposing clinical data collected in the Electronic Healthcare Record (EHR) for use in clinical research. Semantic integration of "siloed" applications across domain boundaries is the raison d'être of the standards-based profiles developed by the Integrating the Healthcare Enterprise (IHE) initiative - an initiative by healthcare professionals and industry promoting the coordinated use of established standards such as DICOM and HL7 to address specific clinical needs in support of optimal patient care. In particular, the combination of two IHE profiles - the integration profile "Retrieve Form for Data Capture" (RFD), and the IHE content profile "Clinical Research Document" (CRD) - offers a straightforward approach to repurposing EHR data by enabling the pre-population of the case report forms (eCRF) used for clinical research data capture by Clinical Data Management Systems (CDMS) with previously collected EHR data. Implement an alternative solution of the RFD-CRD integration profile centered around two approaches: (i) Use of the EHR as the single-source data-entry and persistence point in order to ensure that all the clinical data for a given patient could be found in a single source irrespective of the data collection context, i.e. patient care or clinical research; and (ii) Maximize the automatic pre-population process through the use of a semantic interoperability services that identify duplicate or semantically-equivalent eCRF/EHR data elements as they were collected in the EHR context. The RE-USE architecture and associated profiles are focused on defining a set of scalable, standards-based, IHE-compliant profiles that can enable single-source data collection/entry and cross-system data reuse through semantic integration. Specifically, data reuse is realized through the semantic mapping of data collection fields in electronic Case Report Forms (eCRFs) to data elements previously defined as part of patient care-centric templates in the EHR context. The approach was evaluated in the context of a multi-center clinical trial conducted in a large, multi-disciplinary hospital with an installed EHR. Data elements of seven eCRFs used in a multi-center clinical trial were mapped to data elements of patient care-centric templates in use in the EHR at the George Pompidou hospital. 13.4% of the data elements of the eCRFs were found to be represented in EHR templates and were therefore candidate for pre-population. During the execution phase of the clinical study, the semantic mapping architecture enabled data persisted in the EHR context as part of clinical care to be used to pre-populate eCRFS for use without secondary data entry. To ensure that the pre-populated data is viable for use in the clinical research context, all pre-populated eCRF data needs to be first approved by a trial investigator prior to being persisted in a research data store within a CDMS. Single-source data entry in the clinical care context for use in the clinical research context - a process enabled through the use of the EHR as single point of data entry, can - if demonstrated to be a viable strategy - not only significantly reduce data collection efforts while simultaneously increasing data collection accuracy secondary to elimination of transcription or double-entry errors between the two contexts but also ensure that all the clinical data for a given patient, irrespective of the data collection context, are available in the EHR for decision support and treatment planning. The RE-USE approach used mapping algorithms to identify semantic coherence between clinical care and clinical research data elements and pre-populate eCRFs. The RE-USE project utilized SNOMED International v.3.5 as its "pivot reference terminology" to support EHR-to-eCRF mapping, a decision that likely enhanced the "recall" of the mapping algorithms. The RE-USE results demonstrate the difficult challenges involved in semantic integration between the clinical care and clinical research contexts.

1 January 2005 in Drug Safety
Verified
Journal Article
Closed access
PDF file
CBCédric Bousquet
Cédric Bousquet
GLGeorges Lagier
Georges Lagier
ALAgnès Lillo-Le Louët
Agnès Lillo-Le Louët
CBChristine Le Beller
Christine Le Beller
AVAlain Venot
Alain Venot
MJMarie-Christine Jaulent
Marie-Christine Jaulent

30 December 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SDStella Dimitsaki
Stella Dimitsaki
PNPantelis Natsiavas
Pantelis Natsiavas
MJMarie-Christine Jaulent
Marie-Christine Jaulent
Background: Artificial intelligence (AI) applied to real-world data (RWD; eg, electronic health care records) has been identified as a potentially promising technical paradigm for the pharmacovigilance field. There are several instances of AI approaches applied to RWD; however, most studies focus on unstructured RWD (conducting natural language processing on various data sources, eg, clinical notes, social media, and blogs). Hence, it is essential to investigate how AI is currently applied to structured RWD in pharmacovigilance and how new approaches could enrich the existing methodology. Objective: This scoping review depicts the emerging use of AI on structured RWD for pharmacovigilance purposes to identify relevant trends and potential research gaps. Methods: The scoping review methodology is based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. We queried the MEDLINE database through the PubMed search engine. Relevant scientific manuscripts published from January 2010 to January 2024 were retrieved. The included studies were “mapped” against a set of evaluation criteria, including applied AI approaches, code availability, description of the data preprocessing pipeline, clinical validation of AI models, and implementation of trustworthy AI criteria following the guidelines of the FUTURE (Fairness, Universality, Traceability, Usability, Robustness, and Explainability)-AI initiative. Results: The scoping review ultimately yielded 36 studies. There has been a significant increase in relevant studies after 2019. Most of the articles focused on adverse drug reaction detection procedures (23/36, 64%) for specific adverse effects. Furthermore, a substantial number of studies (34/36, 94%) used nonsymbolic AI approaches, emphasizing classification tasks. Random forest was the most popular machine learning approach identified in this review (17/36, 47%). The most common RWD sources used were electronic health care records (28/36, 78%). Typically, these data were not available in a widely acknowledged data model to facilitate interoperability, and they came from proprietary databases, limiting their availability for reproducing results. On the basis of the evaluation criteria classification, 10% (4/36) of the studies published their code in public registries, 16% (6/36) tested their AI models in clinical environments, and 36% (13/36) provided information about the data preprocessing pipeline. In addition, in terms of trustworthy AI, 89% (32/36) of the studies followed at least half of the trustworthy AI initiative guidelines. Finally, selection and confounding biases were the most common biases in the included studies. Conclusions: AI, along with structured RWD, constitutes a promising line of work for drug safety and pharmacovigilance. However, in terms of AI, some approaches have not been examined extensively in this field (such as explainable AI and causal AI). Moreover, it would be helpful to have a data preprocessing protocol for RWD to support pharmacovigilance processes. Finally, because of personal data sensitivity, evaluation procedures have to be investigated further.

1 January 2015 in Methods of Information in Medicine
Verified
Journal Article
Closed access
PDF file
BSB. Séroussi
B. Séroussi
NGN. Griffon
N. Griffon
GKG. Kerdelhué
G. Kerdelhué
MJM. -C. Jaulent
M. -C. Jaulent
JBJ. Bouaud
J. Bouaud
JLJ. -B. Lamy
J. -B. Lamy
Summary: Background: Each year, the International Medical Informatics Association Yearbook recognizes significant scientific papers, labelled as “best papers”, published the previous year in the subfields of biomedical informatics that correspond to the different section topics of the journal. For each section, about fifteen pre-selected “candidate” best papers are externally peer-reviewed to select the actual best papers. Although based on the available literature, little is known about the pre-selection process.Objective: To move toward an explicit formalization of the candidate best papers selection process to reduce variability in the literature search across sections and over years.Methods: A methodological framework is proposed to build for each section topic specific queries tailored to PubMed and Web of Science citation databases. The two sets of returned papers are merged and reviewed by two independent section editors and citations are tagged as “discarded”, “pending”, and “kept”. A protocolized consolidation step is then jointly conducted to resolve conflicts. A bibliographic software tool, BibReview, was developed to support the whole process.Results: The proposed search strategy was fully applied to the Decision Support section of the 2013 edition of the Yearbook. For this section, 1124 references were returned (689 PubMed-specific, 254 WoS-specific, 181 common to both databases) among which the 15 candidate best papers were selected.Conclusions: The search strategy for determining candidate best papers for an IMIA Yearbook’s section is now explicitly specified and allows for reproducibility. However, some aspects of the whole process remain reviewer-dependent, mostly because there is no characterization of a ”best paper“.

1 August 2005 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
CBCédric Bousquet
Cédric Bousquet
CHCorneliu Henegar
Corneliu Henegar
ALAgnès Lillo-Le Louët
Agnès Lillo-Le Louët
PDPatrice Degoulet
Patrice Degoulet
MJMarie-Christine Jaulent
Marie-Christine Jaulent